World & # 039; s first MALE birth control can only last six months

A contraceptive for men may be just around the corner in India, where scientists report having completed clinical trials for a drug injected into the man's groin.


The only thing left is that the Indian equivalent of the US Food and Drug Administration (FDA) approves the contraceptive shot, which lasts for 13 years, the Hindustan Times reported.

Then men can stand in line to be anesthetized to get a shot of synthetic material in their testicles to close the tube that would deliver sperm to the penis.

If the drug can take that last hurdle, it is the first approved male contraception in the world, which ultimately offers alternative sterilization through vasectomy for men and the abundance of contraceptives used by women.

& # 39; The world's first male contraception may have been just a few months away, according to Indian scientists who have completed clinical trials for a sperm-blocking injection (file)

& # 39; The world's first male contraception may have been just a few months away, according to Indian scientists who have completed clinical trials for a sperm-blocking injection (file)

& # 39; The product is ready, with regulatory approvals pending the Drugs Controller only, & # 39; Dr. told RS Sharma, the senior scientists at the aid of the project, to Hindustan Times.


Dr. told Sharma The wire he has been working on drugs for a quarter of a century.

The scientist who developed the polymer that forms the core of the full contraceptive treatment, Dr. Sujoy Kumar Guha, is working on it even longer – 37 years.

In India, more than half of couples use birth control, according to the Hindustan Times.

Sterilization is the most popular form of contraception and is largely done through tubal ligations in women.

Less than one percent of sterilization procedures are performed on men.

In the US, 99 percent of women of reproductive age have used some form of birth control at some point in their sexually active life.

Around 60 percent currently use a method.


More than 70 percent of women who use contraceptives use non-permanent forms, including the most popular form, the pill, or less dispersed patches, injections, implants, rings, and IUDs.

Approximately 22 percent of women have undergone sterilization procedures. Only seven percent of the population who use contraception prevents pregnancy through male sterilization.

This means that in both the US and India, women are generally responsible for birth control and get side effects that, for the most popular form, are the pill: spotting, weight gain, mood swings, nausea, acne, swelling and breast sensitivity and breakthrough bleeding between periods.

Male contraceptives had entered clinical trials several times in the US, but they eventually failed or were called off because the side effects were considered unbearable for men.

The side effects are strikingly similar to those experienced during birth control.


But the Indian Council of Medical Research (ICMR) team has done something unprecedented: they have completed all three rounds of clinical trials with a large number of men.

According to the Hindustan Times, the new injectable is 97.3 percent effective and Dr. Sharma that the 303 participants reported no side effects.

When the drug gets the final approval, men are anesthetized for the injection.

The polymer, known as reversible inhibition of sperm under supervision (RISUG), is then injected into the vas deferens, the tube that delivers sperm from the testicles to the penis, where it is released into the ejaculate.

It will eventually be finished in about 13 years.


& # 39; The product can safely be called the world's first male contraceptive, & # 39; said Dr. Sharma.

. (TagsToTranslate) Dailymail (t) health

- Advertisement -